# Noise-Induced Hearing Loss-Acute Exposure Treatment

> **NCT04768569** · PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 24 (actual)

## Conditions studied

- Hearing Loss, Noise-Induced

## Interventions

- **DRUG:** Zonisamide 100Mg Cap
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04768569
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-04
- **Primary completion:** 2023-09-29
- **Final completion:** 2023-09-29
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** PINIHL Program terminated by DoD
- **Last updated:** 2025-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768569, "Noise-Induced Hearing Loss-Acute Exposure Treatment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04768569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*